Trends for 2023: What's coming next in pharma marketing and drug commercialization?
With 2022 almost in the rearview mirror, it’s time to look ahead at what to expect in pharma marketing, advertising and drug commercialization strategies for 2023. This year marked the first full year of widely available Covid-19 vaccines — plus multiple treatments and new boosters — and while no one is suggesting the crisis is over, most agree it is at least moving toward an endemic phase.
Along with that change also comes a pendulum swing back, at least somewhat, toward pre-pandemic pharma practices. Chief among those is a return to in-person sales rep and medical liaison meetings with healthcare professionals.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters